research Reply to Comment on: The Gabrin Sign
Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.
Search
for
Sort by
Research
420-450 / 1000+ results 
research Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.
research Relationship Between Early-Onset Androgenetic Alopecia and Metabolic Syndrome: Systematic Review and Meta-Analysis
Early-onset male baldness is significantly linked to a higher risk of metabolic syndrome.
research Second-To-Fourth Digit Ratio and Age Predicting the Severity of Androgenetic Alopecia: A Cross-Sectional Study
Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.
research Association of Early-Onset Androgenetic Alopecia with Metabolic Syndrome: A Case-Control Study on 46 Patients in a Tertiary Care Hospital in South India
Early-onset hair loss may be linked to higher risk of metabolic syndrome.
research Correlation of Androgenetic Alopecia and Early Onset Coronary Heart Disease in Men
Men with early-onset baldness may have a higher risk of heart disease.
research Correlation of Carotid Intima Media Thickness and Aortic Stiffness Index with Androgenetic Alopecia
Men with severe hair loss may have a higher risk of heart disease.
research Faculty Opinions Recommendation of Association of Androgenetic Alopecia with Mortality from Diabetes Mellitus and Heart Disease
People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.
research Fundamentals
Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.
research Evaluation of Serum Amyloid A3 in Young Adult Males with Early Onset of Androgenic Alopecia
Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.
research Gonadal Profile in Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Syndrome Exist?
Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.
research The Relationship of Androgenetic Alopecia Severity with Epicardial Fat Thickness
More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.
research Comment on: The Gabrin Sign
The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.
research Why Odds Ratios Can Be Tricky Statistics
Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.
research Post-Finasteride Syndrome: A Review of Current Literature
Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.
research Androgenetic Alopecia in Transgender Men: A Literature Review and Therapeutic Insights
Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.
research Prevalence, Severity, and Associated Factors of Androgenetic Alopecia in the Dermatology Outpatient Clinic: A Retrospective Study
Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.
research Estimation of Serum Aldosterone, Free Testosterone, and DHEA-S and Scalp Androgen and Aldosterone Receptors in Female Androgenetic Alopecia: Is the Mystery Solved?
High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.
research A Comparative Study of Dyslipidemia in Men and Women with Androgenic Alopecia
People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.
research Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)
Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.
research Lifestyle Diseases and the Hair Growth Cycle: A Multidisciplinary Approach Using Nourkrin with Marilex, a Proteoglycan Replacement Therapy, for Anagen Induction and Maintenance
The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.
research Androphenotypic Features in Patients with Coronary Artery Disease
Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.
research Clinical Snippets: Hair Growth, Androgenetic Alopecia, Psoriasis, Hidradenitis Suppurativa, and Alopecia Areata
R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.
research Characterization of Lipid Profile in Psoriasis, Acne Vulgaris, and Androgenetic Alopecia: A Case-Control Study
Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.
research The Relationship Between Early-Onset Androgenetic Alopecia and Metabolic Syndrome: Systematic Review and Meta-Analysis
Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.
research Association of Androgenetic Alopecia with Coronary Artery Disease: A Case-Control Study
Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.
research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
research The Women's Hair Growth Questionnaire: Development and Validation of a Patient-Reported Measure for Treatment Efficacy in Androgenetic Alopecia
AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.
research The Efficacy and Safety of Dutasteride Compared with Finasteride in Treating Men with Androgenetic Alopecia: A Systematic Review and Meta-Analysis
Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.
research Efficacy and Safety of Oral Minoxidil 5 mg Daily During 24-Week Treatment in Male Androgenetic Alopecia
Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.